Thanks all for the responses. With 50 patients in phase 2a in Aus & Korea, plus who knows how many patients in the US arm of phase 2, it makes sense to a combined phase 2b/3 if FDA agrees. Fingers crossed. If that happens we may be looking at an marketing approval in 2026.
DYOR.
Thanks all for the responses. With 50 patients in phase 2a in...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.59M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 14.5¢ | $11.59K | 77.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 132332 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 130580 | 3 |
View Market Depth
| Last trade - 10.19am 27/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |